JOIN USBiomarkers to distinguish between bacterial and viral infections
A recent study by the Indian Institute of Science (IISc), Bengaluru has identified a set of molecular biomarkers that can be used in the differential diagnosis of acute bacterial and viral infections such as Covid-19.
These biomarkers are different messenger RNA (mRNA) molecules found in the blood, and differences in their levels can detect and predict with high probability if an infection is viral or bacterial. The study has been published in The Lancet.
Scientists said that the research was prompted by the current Covid-19 pandemic. Challenges in treating such diseases is misdiagnosis, which can lead to trial-and-error treatments, and improper use of antibiotics. “Identifying the correct type of infection is therefore critical,” IISc said in a statement.
Use of antibiotics
The human body responds to bacterial and viral infections differently. It produces different types of molecules ‒ such as proteins and RNA ‒ in the blood, depending on the type of infection. While antibiotics can treat bacterial infections, they are ineffective against viral infections.
However, indiscriminate use of antibiotics to treat any kind of infection has given rise to bacterial strains that are now resistant to our entire arsenal of antibiotics.
“Antibiotics are given even for viral infections in some cases because of misdiagnosis. With current methods, it can take a lot of time to test for bacterial or viral infections,” explained first author of the study Prof Sathyabaarathi Ravichandran.
A quick method to detect acute viral and bacterial infections and distinguish between them can be immensely useful in the clinic, as accurate diagnosis will win half the battle and guide the clinician towards the optimal treatment path. It will also prevent the rise of such anti-microbial resistance.
Blood-based testing
In the new study, the researchers have developed such a test using patient blood transcriptomes and sophisticated computational modelling.
A transcriptome is a full set of mRNA molecules expressed by a biological cell which is measured using next-generation sequencing (NGS)
technologies. During an infection, there are specific genes that get turned on and these, in turn, lead to higher amounts of specific mRNAs and ultimately, higher amounts of the corresponding proteins.
The scientists analysed transcriptomic data of patients (from publicly available databases and samples collected from MS Ramaiah Medical College, Bengaluru in collaboration with a clinical team), and discovered a ten-gene RNA signature in the patients’ blood that is produced in varying quantities for viral and bacterial infections.
To make it useful in the clinic, the researchers devised a standalone score called VB10, which could be used for diagnosis, monitoring the stage of recovery after infection, and estimating the severity of the infection. VB10 accurately indicated whether a given blood sample had a bacterial or viral infection, across different bacteria and viruses and across different age groups.
Lab to clinic
The authors suggest that the test could be useful for differentiating Covid-19 infection from bacterial infections as well. As soon as transcriptomic data became available for Covid-19, the team tested their approach and found that the test scores could differentiate between Sars-CoV-2 infection and common bacterial respiratory infections.
The team hopes to begin a trial study to translate their research from the lab to the clinic. The researchers expect the breakthrough to be useful early on during the infection, and work against any strain.